96 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
for future issuance under our employee share purchase plan as of June 30, 2024, as well as any future increases in the number of ordinary shares reserved … shares reserved for future issuance under our employee share purchase plan as of June 30, 2024, as well as any future increases in the number of ordinary
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
, officer or employee thereof, or, to the Company’s knowledge, any agent or representative of the Company or of any of its subsidiaries or affiliates, has … of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
; and
2,708,415 ordinary shares reserved for future issuance under our employee share purchase plan as of June 30, 2024, as well as any future increases … ordinary shares reserved for future issuance under our employee share purchase plan as of June 30, 2024, as well as any future increases in the number
S-3ASR
EX-4.6
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
to the Trustee.
“Opinion of Counsel” means a written opinion of counsel, who may be counsel for the Company or who may be an employee of or other counsel … past, present or future shareholder, employee, officer, director or agent, as such, of the Company or any successor, either directly or through
S-3ASR
EX-4.4
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
to the Trustee.
“Opinion of Counsel” means a written opinion of counsel, who may be counsel for the Company or who may be an employee of or other counsel … or future shareholder, employee, officer, director or agent, as such, of the Company or any successor, either directly or through the Company or any
S-3ASR
dcqebr 95vy
11 Sep 24
Automatic shelf registration
4:01pm
DEFA14A
ebt7ar
20 May 24
Additional proxy soliciting materials
8:48pm
PRE 14A
79h 2n12w99ba0i
26 Apr 24
Preliminary proxy
4:36pm
424B5
qh6y9j
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-1.1
u1bqe0vr1bkw
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
7pjr2s6ykko
23 Apr 24
Prospectus supplement for primary offering
5:16pm
S-8
1o22g
28 Mar 24
Registration of securities for employees
5:01pm
S-8
6q5o2ssoil9ouod76
28 Mar 24
Registration of securities for employees
5:01pm
S-8
EX-5.1
6ztw31335ir20xspx
28 Mar 24
Registration of securities for employees
5:01pm